SAB Biotherapeutics Inc

SAB Biotherapeutics Inc(SABS)の株価予測

$3.180

+0.061 (+1.92%)終値時点

価格予想

1-Day Price Prediction
-0.24%
1-Week Prediction
+0.88%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

アプリで開くと、より長期の予想を確認できます。

Loading chart…

類似チャート分析による SABS の予測・予想

Alphio's SABS stock price prediction model matches the current SAB Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.17 (-0.24%). The 1-week path is $3.21 (+0.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

SAB Biotherapeutics Inc 株は買うべき?

SAB Biotherapeutics Inc is a good buy right now due to its current price of $3.30, which is significantly below the analyst price targets of $11 and $13. The stock has shown a strong recent performance with a 5-day change of +18.28%, indicating positive momentum. However, the primary risk is the company's ongoing net losses, with a reported net loss of $18.9 million for Q1 2026, which raises concerns about its financial health.

SABS の株価は Wednesday に $3.18 で引け、その前に上昇 +1.92%

SAB Biotherapeutics Inc (SABS) last closed at $3.1800001, gaining +1.92%. These facts feed the 1-day and 1-week SABS price prediction above.

予想の要因

SAB Biotherapeutics Inc(SABS)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

類似チャートパターン

直近の値動きが SABS に最も近い銘柄を、類似度順に表示します。

SABS の季節性分析

Historically the probability of a positive November return for SABS is 19.05%. December offers the highest probability of a positive month at 37.21%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める